Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Intravenous route

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44338   clinical trials with a EudraCT protocol, of which   7368   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    186 result(s) found for: Intravenous route. Displaying page 1 of 10.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2014-004282-25 Sponsor Protocol Number: CHUBX2014/10 Start Date*: 2015-03-25
    Sponsor Name:CHU de Bordeaux
    Full Title: Subcutaneous route and pharmacology of metoclopramide - SOPHA-Méto
    Medical condition: Digestive disorder (Nausea and vomiting) in palliative care and oncology
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-000285-38 Sponsor Protocol Number: APHP190020 Start Date*: 2019-08-21
    Sponsor Name:London School of Hygiene and Tropical Medicine
    Full Title: Pharmacokinetics of Tranexamic Acid after oral, intramuscular or intravenous administration: a prospective, randomised, cross-over trial in healthy volunteers.
    Medical condition: healthy volunteers
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2005-000108-15 Sponsor Protocol Number: KCL/SLAM-CT2005-01 Start Date*: 2005-03-11
    Sponsor Name:Institute of Psychiatry, Kings College London & South London and Maudsley NHS Trust
    Full Title: Pharmacokinetic and pharmacodynamic properties of oral, intramuscular and intravenous methadone in methadone maintenance patients
    Medical condition: Opioid dependence
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Temporarily Halted)
    Trial results: (No results available)
    EudraCT Number: 2021-003427-14 Sponsor Protocol Number: AHUS_PAL_21_01 Start Date*: 2021-12-20
    Sponsor Name:Akershus University Hospital
    Full Title: A randomized controlled trial of subcutaneous versus intravenous morphine when switching from oral to parenteral route in palliative cancer patients
    Medical condition: Cancer pain not responding to oral opioids in palliative cancer patient, where switching to the parenteral route is indicated.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NO (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-004742-16 Sponsor Protocol Number: FARM823BHC Start Date*: 2013-01-04
    Sponsor Name:AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI
    Full Title: Evaluation of the risk of nephrotoxicity caused by the intravenous administration of nonionic iodinated contrast media
    Medical condition: The present study was designed to determine the incidence of serious complications with special reference to contrast induced nephropaty (CIN) in patients receiving iv iodinated contrast media (I...
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-004607-39 Sponsor Protocol Number: 2013-00460739 Start Date*: 2014-04-11
    Sponsor Name:CUB Hopital Erasme
    Full Title: Safety of preoperative administration of hemin to reduce the risk of acute kidney injury after on-pump cardiac surgery: a pilot randomised study in double blind.
    Medical condition: Acute kidney injury which is associated with on-pump cardiac surgery
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2019-000898-23 Sponsor Protocol Number: 2019/KEP/218 Start Date*: 2019-08-01
    Sponsor Name:London School of Hygiene and Tropical Medicine
    Full Title: Pharmacokinetics of intramuscular tranexamic acid in trauma patients: a clinical trial
    Medical condition: Traumatic haemorrhage
    Disease: Version SOC Term Classification Code Term Level
    20.0 10022117 - Injury, poisoning and procedural complications 10053476 Traumatic haemorrhage PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-005905-21 Sponsor Protocol Number: AOI/2008/EJ-02 Start Date*: 2009-04-17
    Sponsor Name:CHU de Nîmes
    Full Title: Cinétique du taux de protéasome circulant au cours du traitement par inhibiteur du protéasome (bortézomib, Velcade®) au cours du myélome multiple
    Medical condition: Myélome multiple
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2011-004070-29 Sponsor Protocol Number: E2011OBPROCHIR Start Date*: 2011-10-04
    Sponsor Name:Hopital Erasme
    Full Title: What are the optimal doses of cephalosporins of first and second generation to manage obese patients?
    Medical condition: Antibiotic prophylaxis in digestive surgery or any other surgery with antibiotic prophylaxis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10036898 Prophylaxis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2013-003349-41 Sponsor Protocol Number: ERASMECMI Start Date*: 2013-10-03
    Sponsor Name:Erasme hospital
    Full Title: what are the optimal doses of cefuroxime for cirrhotic patients?
    Medical condition: Cirrhotic patients with infection requiring treatment with cefuroxime
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004871 10024678 Liver failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2012-003442-32 Sponsor Protocol Number: ML28589 Start Date*: 2013-01-08
    Sponsor Name:ROCHE SAS
    Full Title: AN OPEN-LABEL, RANDOMIZED, MULTICENTER PHASE III STUDY IN PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER RESPONDING TO FIRST LINE TREATMENT WITH INTRAVENOUS TRASTUZUMAB FOR AT LEAST 3 YEARS A...
    Medical condition: HER2-positive metastatic breast cancer
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10055113 Breast cancer metastatic PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2008-008143-24 Sponsor Protocol Number: gas alogenati Start Date*: 2009-02-12
    Sponsor Name:AZIENDA OSPEDALIERA SAN GERARDO DI MONZA
    Full Title: Inhalatorial sedation in patient with SAH versus conventional intravenus sedation
    Medical condition: sub-arachnoid haemorrage
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-004066-14 Sponsor Protocol Number: EMG-2006 en Start Date*: 2006-08-22
    Sponsor Name:Erasme hospital
    Full Title: Etude des effets de l'enoximone sur la sensibilité du chémorécepteur.
    Medical condition: healthy subjects
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2004-001789-42 Sponsor Protocol Number: IC01/04/DKP Start Date*: 2004-12-07
    Sponsor Name:Laboratorios Menarini, S.A.
    Full Title: A MULTICENTRE CLINICAL TRIAL EVALUATING THE ANALGESIC EFFICACY AND SAFETY OF DEXKETOPROFEN TROMETAMOL (50 mg i.v. FOLLOWED BY AN ORAL DOSAGE OF 25 mg t.i.d.) VERSUS METAMIZOL (2 g i.v. and 575 mg t...
    Medical condition: Patients who underwent ambulatory surgery consisting in unilateral inguinal mesh hernioplasty
    Disease: Version SOC Term Classification Code Term Level
    7.0 10022025 LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-000081-13 Sponsor Protocol Number: BA 17284 Start Date*: 2004-09-07
    Sponsor Name:F Hoffmann-La Roche Ltd
    Full Title: A randomized, controlled, open-label, multi-center, parallel group study to demonstrate efficacy and safety of RO0503821 when administered with pre-filled syringes for the maintenance treatment of ...
    Medical condition: Patients with Chronic Kidney Disease who are on dialysis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-001809-14 Sponsor Protocol Number: E2015-PK-HD-PTAZ-MERO-CTAZ Start Date*: 2015-06-24
    Sponsor Name:Hopital Erasme
    Full Title: Beta-Lactams (ceftazidime, piperacilline-tazobactam, meropenem) dosing scheme validation in septic hemodialysed patient
    Medical condition: sepsis in patient undergoing dialysis for renal insufficiency
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004862 10040054 Sepsis, bacteraemia, viraemia and fungaemia NEC HLT
    18.0 100000004869 10012347 Dependence on renal dialysis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2015-002706-36 Sponsor Protocol Number: VASOPRESSOR-LPS Start Date*: 2016-01-06
    Sponsor Name:Radboudumc
    Full Title: The effects of different vasopressors on the innate immune response during experimental human endotoxemia, a pilot proof-of-principle study
    Medical condition: Possible future indications: infectious diseases which require vasopressor therapy.
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2013-004987-80 Sponsor Protocol Number: 2013-Colistin Start Date*: 2014-08-28
    Sponsor Name:CUB - Hôpital Erasme
    Full Title: Colistin use in Cystic Fibrosis patients: pharmacokinetic studies (intravenous administration) in relation with pharmacodynamics, tolerance profile and risk of selection of resistance.
    Medical condition: Colistin use in Cystic Fibrosis patients
    Disease: Version SOC Term Classification Code Term Level
    16.1 10010331 - Congenital, familial and genetic disorders 10011762 Cystic fibrosis PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-001573-10 Sponsor Protocol Number: E2011HDinfection Start Date*: 2012-01-24
    Sponsor Name:Hôpital Erasme
    Full Title: optimization of doses of broad spectrum B-lactames (ceftazidim and meropenem) and vancomycin in septic patient traeted with chronic hemodialysis.
    Medical condition: hemodialysis oligoanuria sepsis
    Disease: Version SOC Term Classification Code Term Level
    14.0 10021881 - Infections and infestations 10040054 Sepsis, bacteraemia, viraemia and fungaemia NEC HLT
    14.0 10042613 - Surgical and medical procedures 10066622 Chronic hemodialysis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2007-004580-21 Sponsor Protocol Number: Start Date*: 2007-09-14
    Sponsor Name:Erasme Hostpital - ULB
    Full Title: 3T versus 1.5 T MR cholangiography using Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic acid (Primovist)
    Medical condition: patients with known or suspected biliary disease will be enrolled and image quality of the MR cholangiography images will be assessed after Primovist administration. Biliary disease can include: bi...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 25 19:57:26 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA